Chief Technology & Innovation Officer, Ra Pharmaceuticals
Clinical Data Update on Zilucoplan
Alonso Ricardo, PhD serves as Chief Technology and Innovation Officer of Ra Pharmaceuticals Inc. since March 2019 and he has been its Head of Research since 2019. He served as serves as Vice President of Research & Development at Ra Pharmaceuticals, Inc. until March 2019 and served as its Senior Director of R&D. Mr. Ricardo joined Ra in 2010 and has held a variety of roles with increasing responsibility. Following graduation, he joined the faculty of the Universidad de los Andes in Bogota, Colombia where he performed research in peptide macrocyclization and Bioorganic Chemistry. In 2006 he became an HHMI Research Associate with Professor Jack W. Szostak, working in Synthetic Biology at Harvard University and the Massachusetts General Hospital. He received a PhD in Chemistry from the University of Florida.